Error: Could not add to watchlist. X

Aberdeen Swiss Funds Global Pharma Equity Fund

+ Watchlist
ABPH:SW
SIX Swiss Ex
1,568.00
USD
0.00
0.00%
As of 11:43 AM EST on 2/10/2016.
Open
1,568.00
Previous Close
1,568.00
1 Yr Return
-4.71%
YTD Return
-9.15%
Open
1,568.00
Volume
0
Previous Close
1,568.00
1 Yr Return
-4.71%
YTD Return
-9.15%
NAV (on -)
-
Total Assets (m USD) (on 02/09/2016)
104.594
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
-
Last Dividend (on 11/17/2015)
4.66
Dividend Indicated Gross Yield
0.30%
Expense Ratio
1.66%
3 Mo Return
-7.18%
3 Yr Return
-
5 Yr Return
-
Top Fund Holdings
Name Position Value % of Fund
Novo Nordisk A/S 188.20 k 10.36 m 8.91
Novartis AG 118.70 k 10.16 m 8.73
Roche Holding AG 37.50 k 10.05 m 8.64
CVS Health Corp 96.10 k 9.04 m 7.77
Johnson & Johnson 84.40 k 8.54 m 7.35
Astellas Pharma Inc 554.10 k 7.79 m 6.70
Teva Pharmaceutical Industries 121.50 k 7.65 m 6.57
L'Oreal SA 31.00 k 5.49 m 4.72
Baxter International Inc 132.20 k 4.98 m 4.28
Sysmex Corp 66.50 k 4.15 m 3.57
Profile
Aberdeen Swiss Equity Fund Global Pharma is an open-end fund incorporated in Switzerland. The Fund invests worldwide in companies that are active in the pharmaceuticals, biotechnology and medical technology sectors. The Fund focuses on the United States and offers investors a transparent way to invest in the complex pharmaceuticals and biotechnology sectors.
ADDRESS
Credit Suisse Asset Management Funds
Sihlcity - Kalandergasse 4
CH-8070 Zurich
Switzerland
PHONE
41-44-335-11-11 Tel